Maia M. Watts-Bosca
Valencia, VC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Real-World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA Registry.
Journal: Alimentary pharmacology & therapeutics
Published: March 28, 2026
Persistence, Effectiveness, and Safety of Upadacitinib in Crohn's Disease and Ulcerative Colitis in Real Life: Results From a Spanish Nationwide Study (Ureal Study).
Journal: The American journal of gastroenterology
Published: July 17, 2024
An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study.
Journal: European journal of clinical investigation
Published: April 24, 2024
Combination of granulocyte-monocyte apheresis and ustekinumab: Multicentre and retrospective study.
Journal: Gastroenterologia y hepatologia
Published: December 29, 2023
Benefits of Paediatric to Adult Transition Programme in Inflammatory Bowel Disease: The BUTTERFLY Study of GETECCU and SEGHNP.
Journal: Journal of clinical medicine
Published: May 15, 2023
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case-Control Study (COVID-19-EII).
Journal: Journal of clinical medicine
Published: September 18, 2022
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety.
Journal: The American journal of gastroenterology
Published: July 13, 2022
Ustekinumab and vedolizumab for the prevention of postoperative recurrence of Crohn's disease: Results from the ENEIDA registry.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: April 06, 2022
Association of golimumab trough concentrations during maintenance with clinical, biological, endoscopic and histologic remission in patients with ulcerative colitis.
Journal: Alimentary pharmacology & therapeutics
Published: March 01, 2022
Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry.
Journal: Journal of clinical medicine
Published: December 09, 2021
Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients.
Journal: Frontiers in medicine
Published: November 28, 2021
Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry.
Journal: Journal of Crohn's & colitis
Published: April 16, 2021
Last Updated: 09/26/2026